Ophthalmic Comprehensive Reports

2023 Retinal Pharmaceuticals Market Report: Global Analysis for 2022 to 2028, August, 2023

The “2023 Retinal Pharmaceuticals Market Report” features new sales and disease prevalence forecasts through 2028. The report now covers adoption plans for complement inhibitors and new anti-VEGFs by ophthalmologists in the United States and Western Europe, as well as treatment patterns for anti-VEGFs. In addition, it includes IVT injection shares by drug in the United States and Western Europe. 

The new report also evaluates more development-stage categories, therapies, and companies.

Related Reports

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more